SHH and hepatocellular carcinoma: Antagonists of the SHH pathway signaling, such as cyclopamine and GANT 61, have shown the ability to downregulate TPX2, suggesting that SHH signaling enhances cellular proliferation in HCC through the regulation of the FOXM1-TPX2 signaling pathway [40].